Figure 2.

Note: *In the case of ofatumumab and ocrelizumab, one possibility for monitoring would be confirming B cell levels. Disease modifying therapies in family planning.

Note: *In the case of ofatumumab and ocrelizumab, one possibility for monitoring would be confirming B cell levels. Disease modifying therapies in family planning.